Clinical trial Recruiting at 5 sites Observational Ages 5 and up

Understanding what makes care complex for children and young people with serious illnesses

Official title: CHESS - Complexity and Outcomes in Health, Education, and Social Support Among Children and Young People With Life-limiting Conditions: Establishing a Multisectoral Collaboration and Conceptual Framework to Advance Evidence and Practice.

Run by King's College London · NCT07102433 · Data updated 2026-11-12

This project tests how to define and measure complexity in the care of children and young people with life-limiting or lifethreatening conditions, by gathering input from families and health and social care professionals.

Quick facts

Study typeObservational
Ages5 Years and up
SexAll
Enrollment170 (estimated)
SponsorKing's College London
Academic / other
Locations5 sites (Birmingham and 4 other locations)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedAugust 5, 2026
Trial IDNCT07102433 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5-17 with life-limiting or life-threatening conditions, their parents or carers, bereaved parents, and professionals with relevant experience across health, education, and social care.

Probably not a fit

The study is observational and exploratory; individual participants may not directly benefit from participation beyond contributing to knowledge and future improvements.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CHESS study seeks to build a shared, evidence-informed understanding of complexity in pediatric life-limiting conditions. It involves a multidisciplinary team and is funded by NIHR to lay groundwork for future design and implementation work. The project collects perspectives from children aged 5-17, parents, bereaved families, and professionals across healthcare, education, and social care. Activities include interviews and qualitative methods to map how medical, educational, and social needs intersect and how services can be better integrated. The aim is to inform resource allocation, service design, and policy to improve coordinated care for this vulnerable population.

Why it matters

Potential benefit: A clearer, agreed definition of complexity could lead to more consistent, coordinated, and better-resourced care for children and young people with life-limiting conditions.

How similar studies have gone: Previous work in this area suggests that multi-stakeholder understanding of complexity can reveal gaps in care and support better-integrated services.

Who can join: the full rules

Show full inclusion / exclusion criteria
Stage 1 - Interviews

Inclusion Criteria:

* Children (5-17 years) with any life-limiting condition defined using the UK Together for Short Lives widely adopted 4 categories of life-limiting/life-threatening conditions among children.
* Parents/carers of children (0-17 years old) with a life-limiting conditions.
* Bereaved parents of a child who had a life-limiting condition (at least 3 months since bereavement).
* Healthcare professionals (medicine, nursing, allied health professionals), social care providers, education teaching and therapy staff with \> 6 months experience of caring for children with life-limiting conditions.

Exclusion Criteria:

* Children unable to communicate via an interview, using 'draw and talk' or play methods, Talking MatsTM, or via their parents.
* Children that speak languages not supported by NHS translation services.
* Any child or young person for whom the PI believes participation in the study may induce undue psychological distress.
* Parents/carers are unable to provide consent/assent to participate in interviews.
* Parents/carers that speak languages not supported by NHS translation services.
* Parents who are recently bereaved (\<3 months).
* Any parent/carer for whom the PI believes participation in the study may induce undue psychological distress (e.g. parents of children who may be receiving end-of-life care).
* Professionals with \<6 months experience of caring for children with life-limiting conditions.

Stage 2 - Workshops

Inclusion criteria:

* Parents or carers of children with a life-limiting condition (0-17 years old).
* Bereaved parents of a child who had a life-limiting condition (at least 3 months since bereavement).
* Researchers working with or in the field of complexity in children with life-limiting conditions.
* Professionals across child health, social care, and education with experience of working with children with life-limiting conditions for \>6 months.

Exclusion criteria:

* Professionals across child health, social care, and education with \<6 months of experience working with children with life-limiting conditions.
* Parents, carers, or professionals that are unable to provide consent or assent.
* Children with life-limiting/life-threatening conditions will not be included in the workshops
* Parents who are recently bereaved (\<3 months) of a child who had a life-limiting condition.

Where it's running

  • Birmingham Children's Hospital
    Birmingham, United Kingdom
    Recruiting
  • Chailey Clinical Services, Sussex Community NHS Foundation Trust
    Chailey, United Kingdom
    Recruiting
  • Shooting Star Children's Hospices
    Hampton, United Kingdom
    Recruiting
  • Guy's and St Thomas' NHS Foundation Trust
    London, United Kingdom
    Recruiting
  • Royal Marsden Hospital
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.